Impact of platelet reactivity on individual thrombin generation in type 3 and 2 von willebrand disease: results from a small prospective study

被引：0
|
作者：
Szanto, T. [1 ,2 ]
Jokela, V. H. [1 ,2 ,3 ]
Jouppila, A. [4 ]
Lassila, R. [1 ,2 ,3 ]
机构：
[1] Univ Helsinki, Cent Hosp, Coagulat Disorders Unit, Dept Hematol,HUSLAB Lab Serv, Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Coagulat Disorders Unit, Dept Clin Chem,HUSLAB Lab Serv, Helsinki, Finland
[3] Univ Helsinki, Fac Med, Helsinki, Finland
[4] Univ Helsinki, Cent Hosp, Res Inst, Helsinki, Finland
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2016年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
VWF19
引用
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [21] Mutation at Arg611 in the von Willebrand factor gene results in unclassifiable type 2 von Willebrand disease
    Nesbitt, IM
    Goodeve, AC
    Daly, ME
    Hampton, KK
    Makris, M
    Preston, FE
    Peake, IR
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2665 - P2665
  • [22] Platelet type von Willebrand disease and registry report: communication from the SSC of the ISTH
    Othman, M.
    Kaur, H.
    Favaloro, E. J.
    Lillicrap, D.
    Di Paola, J.
    Harrison, P.
    Gresele, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (02) : 411 - 414
  • [23] PLATELET AGGREGATION ABNORMALITIES IN PATIENTS VON WILLEBRAND DISEASE TYPE 2B
    Martinez, Y. P.
    Wernicke, P. B.
    Alberto, F.
    Asensio, M.
    Romero, L.
    Agazzoni, M.
    Blanco, A.
    Woods, A.
    Sanchez-Luceros, A.
    HAEMOPHILIA, 2022, 28 : 103 - 104
  • [24] Fanhdi®, efficacy and safety in von Willebrand's disease: prospective international study results
    Bello, I. F.
    Yuste, V. J.
    Molina, M. Q.
    Navarro, F. H.
    HAEMOPHILIA, 2007, 13 : 25 - 32
  • [25] The effect of DDAVP infusion on thrombin generation in platelet-rich plasma of von Willebrand type 1 and in mild haemophilia A patients
    Keularts, IMLW
    Hamulyak, K
    Hemker, HC
    Béguin, S
    THROMBOSIS AND HAEMOSTASIS, 2000, 84 (04) : 638 - 642
  • [26] Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients
    Baronciani, L
    Cozzi, G
    Canciani, MT
    Peyvandi, F
    Srivastava, A
    Federici, AB
    Mannucci, PM
    BLOOD CELLS MOLECULES AND DISEASES, 2003, 30 (03) : 264 - 270
  • [27] Pharmacokinetics of von Willebrand factor and factor VIII coagulant activity in patients with von Willebrand disease type 3 and type 2
    Menache, D
    HAEMOPHILIA, 1998, 4 : 44 - 47
  • [28] The impact of bleeding history, von Willebrand factor and PFA-100® on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD
    Castaman, Giancarlo
    Tosetto, Alberto
    Goodeve, Anne
    Federici, Augusto B.
    Lethagen, Stefan
    Budde, Ulrich
    Batlle, Javier
    Meyer, Dominique
    Mazurier, Claudine
    Goudemand, Jenny
    Eikenboom, Jeroen
    Schneppenheim, Reinhard
    Ingerslev, Jorgen
    Habart, David
    Hill, Frank
    Peake, Ian
    Rodeghiero, Francesco
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (03) : 245 - 251
  • [29] VON WILLEBRAND DISEASE TYPE 3 AND TYPE 1 GENOTYPE RESULTS IN NORTHERN REGION OF TURKEY
    Albayrak, C.
    Albayrak, D.
    HAEMOPHILIA, 2020, 26 : 133 - 133
  • [30] Is gingival bleeding a symptom of type 2 and 3 von Willebrand disease?
    Epping, Lisa
    Miesbach, Wolfgang
    Nickles, Katrin
    Eickholz, Peter
    PLOS ONE, 2018, 13 (01):
12345